the use of a standardized algorithm as a general tool to define the strategy for immunogenicity evaluation of biotechnological medicinal products is not appropriate now because it might ...
The new rule pertains to more than 3,200 food and medicinal products that contain what is ... information,” citing that the FDA’s evaluation and risk assessment concluded Red No. 3 “meets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback